Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) saw a large drop in short interest during the month of November. As of November 30th, there was short interest totalling 154,900 shares, a drop of 27.2% from the November 15th total of 212,800 shares. Based on an average daily trading volume, of 979,800 shares, the days-to-cover ratio is presently 0.2 days.
Reckitt Benckiser Group Price Performance
RBGLY traded up $0.02 during trading on Friday, hitting $12.26. The company’s stock had a trading volume of 229,072 shares, compared to its average volume of 861,540. Reckitt Benckiser Group has a twelve month low of $10.24 and a twelve month high of $15.03. The business’s fifty day simple moving average is $12.33 and its 200 day simple moving average is $11.73. The company has a quick ratio of 0.47, a current ratio of 0.69 and a debt-to-equity ratio of 0.97.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the stock. Sanford C. Bernstein lowered shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 4th. Citigroup raised Reckitt Benckiser Group to a “strong-buy” rating in a report on Tuesday, October 1st. Hsbc Global Res upgraded Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research report on Wednesday. UBS Group raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a report on Wednesday, September 18th. Finally, HSBC raised shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Wednesday. Three research analysts have rated the stock with a hold rating, one has issued a buy rating and four have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Reckitt Benckiser Group currently has a consensus rating of “Buy”.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Further Reading
- Five stocks we like better than Reckitt Benckiser Group
- Retail Stocks Investing, Explained
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Overbought Stocks Explained: Should You Trade Them?
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Using the MarketBeat Stock Split Calculator
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.